157 related articles for article (PubMed ID: 35305599)
1. Comparing six cardiovascular risk prediction models in Haiti: implications for identifying high-risk individuals for primary prevention.
Yan LD; Lookens Pierre J; Rouzier V; Théard M; Apollon A; St Preux S; Kingery JR; Jamerson KA; Deschamps M; Pape JW; Safford MM; McNairy ML
BMC Public Health; 2022 Mar; 22(1):549. PubMed ID: 35305599
[TBL] [Abstract][Full Text] [Related]
2. Polypill for atherosclerotic cardiovascular disease prevention in Haiti: Eligibility estimates in a low-income country.
Yan LD; Rouzier V; Pierre JL; Dade E; Sufra R; Huffman MD; Apollon A; St Preux S; Metz M; Sabwa S; Morisset B; Deschamps M; Pape JW; McNairy ML
Front Epidemiol; 2022; 2():. PubMed ID: 36816341
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.
Uthman OA; Hartley L; Rees K; Taylor F; Ebrahim S; Clarke A
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011163. PubMed ID: 26272648
[TBL] [Abstract][Full Text] [Related]
5. Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data.
Marcus ME; Manne-Goehler J; Theilmann M; Farzadfar F; Moghaddam SS; Keykhaei M; Hajebi A; Tschida S; Lemp JM; Aryal KK; Dunn M; Houehanou C; Bahendeka S; Rohloff P; Atun R; Bärnighausen TW; Geldsetzer P; Ramirez-Zea M; Chopra V; Heisler M; Davies JI; Huffman MD; Vollmer S; Flood D
Lancet Glob Health; 2022 Mar; 10(3):e369-e379. PubMed ID: 35180420
[TBL] [Abstract][Full Text] [Related]
6. External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study.
Al-Shamsi S; Govender RD; King J
BMJ Open; 2020 Oct; 10(10):e040680. PubMed ID: 33115904
[TBL] [Abstract][Full Text] [Related]
7. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
[TBL] [Abstract][Full Text] [Related]
8. Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations.
Gaziano TA; Pandya A; Steyn K; Levitt N; Mollentze W; Joubert G; Walsh CM; Motala AA; Kruger A; Schutte AE; Naidoo DP; Prakaschandra DR; Laubscher R
BMC Med; 2013 Jul; 11():170. PubMed ID: 23880010
[TBL] [Abstract][Full Text] [Related]
9. The Haiti cardiovascular disease cohort: study protocol for a population-based longitudinal cohort.
Lookens J; Tymejczyk O; Rouzier V; Smith C; Preval F; Joseph I; Baptiste RJ; Victor J; Severe P; Apollon S; Dumont E; Forestal G; St Preux S; Rivera V; Seo G; Charles B; Ariste W; Kingery J; Devieux J; Koenig S; Nash D; Fitzgerald D; Safford M; Deschamps MM; Pape J; McNairy M
BMC Public Health; 2020 Nov; 20(1):1633. PubMed ID: 33131500
[TBL] [Abstract][Full Text] [Related]
10. Predicted 10-year risk of cardiovascular disease is influenced by the risk equation adopted: a cross-sectional analysis.
Gray BJ; Bracken RM; Turner D; Morgan K; Mellalieu SD; Thomas M; Williams SP; Williams M; Rice S; Stephens JW;
Br J Gen Pract; 2014 Oct; 64(627):e634-40. PubMed ID: 25267049
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Cardiovascular Disease by the Framingham-REGICOR Equation in the High-Risk PREDIMED Cohort: Impact of the Mediterranean Diet Across Different Risk Strata.
Amor AJ; Serra-Mir M; Martínez-González MA; Corella D; Salas-Salvadó J; Fitó M; Estruch R; Serra-Majem L; Arós F; Babio N; Ros E; Ortega E;
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28288977
[TBL] [Abstract][Full Text] [Related]
12. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.
Yebyo HG; Zappacosta S; Aschmann HE; Haile SR; Puhan MA
BMC Cardiovasc Disord; 2020 Sep; 20(1):418. PubMed ID: 32942999
[TBL] [Abstract][Full Text] [Related]
13. Interpretation of CVD risk predictions in clinical practice: Mission impossible?
Lagerweij GR; Moons KGM; de Wit GA; Koffijberg H
PLoS One; 2019; 14(1):e0209314. PubMed ID: 30625177
[TBL] [Abstract][Full Text] [Related]
14. A comparison of laboratory-based and office-based Framingham risk scores to predict 10-year risk of cardiovascular diseases: a population-based study.
Dehghan A; Ahmadnia Motlagh S; Khezri R; Rezaei F; Aune D
J Transl Med; 2023 Oct; 21(1):687. PubMed ID: 37789412
[TBL] [Abstract][Full Text] [Related]
15. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
[TBL] [Abstract][Full Text] [Related]
16. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.
Ueda P; Woodward M; Lu Y; Hajifathalian K; Al-Wotayan R; Aguilar-Salinas CA; Ahmadvand A; Azizi F; Bentham J; Cifkova R; Di Cesare M; Eriksen L; Farzadfar F; Ferguson TS; Ikeda N; Khalili D; Khang YH; Lanska V; León-Muñoz L; Magliano DJ; Margozzini P; Msyamboza KP; Mutungi G; Oh K; Oum S; Rodríguez-Artalejo F; Rojas-Martinez R; Valdivia G; Wilks R; Shaw JE; Stevens GA; Tolstrup JS; Zhou B; Salomon JA; Ezzati M; Danaei G
Lancet Diabetes Endocrinol; 2017 Mar; 5(3):196-213. PubMed ID: 28126460
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease risk prediction in sub-Saharan African populations - Comparative analysis of risk algorithms in the RODAM study.
Boateng D; Agyemang C; Beune E; Meeks K; Smeeth L; Schulze MB; Addo J; de-Graft Aikins A; Galbete C; Bahendeka S; Danquah I; Agyei-Baffour P; Owusu-Dabo E; Mockenhaupt FP; Spranger J; Kengne AP; Grobbee DE; Klipstein-Grobusch K
Int J Cardiol; 2018 Mar; 254():310-315. PubMed ID: 29407113
[TBL] [Abstract][Full Text] [Related]
18. Validation and comparison of cardiovascular risk prediction equations in Chinese patients with Type 2 diabetes.
Liang J; Li Q; Fu Z; Liu X; Shen P; Sun Y; Zhang J; Lu P; Lin H; Tang X; Gao P
Eur J Prev Cardiol; 2023 Sep; 30(12):1293-1303. PubMed ID: 37315163
[TBL] [Abstract][Full Text] [Related]
19. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
Boytsov S; Logunova N; Khomitskaya Y;
Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
